Vault-13

BIOHAVEN PHARMACTL HLDG CO L BHVN

COM · Common Stock · CUSIP G11196105 · ISIN VGG111961055

1 institutional holders +0 vs Q2 2023
490,422490.4k shares reported held*
$12.8mreported value*
0 new 1 added 0 reduced 0 sold out net bought ≈ $1.0m (+40.0k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $26.01. Options: 0 managers hold calls (— notional), 1 hold puts ($0).

Trends to Q3 2023

Institutional holders

Managers reporting a position, each quarter

0100200300Q3 22: 240Q4 22: 7Q1 23: 2Q2 23: 1Q3 23: 11Q3 22Q4 22Q1 23Q2 23Q3 23
Numbers
QuarterHolders
Q3 2022240
Q4 20227
Q1 20232
Q2 20231
Q3 20231

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
4000400Q4 22: 2 bought or addedQ4 22: 231 cut or sold outQ4 22Q1 23: 0 bought or addedQ1 23: 6 cut or sold outQ1 23Q2 23: 0 bought or addedQ2 23: 1 cut or sold outQ2 23Q3 23: 1 bought or addedQ3 23: 0 cut or sold outQ3 23
Numbers
QuarterBought or addedCut or sold out
Q4 20222231
Q1 202306
Q2 202301
Q3 202310

Biggest buyers

Knoll Capital Management, LLC Added +40,000+40.0k

Biggest sellers

None

Biggest calls

None

Biggest puts

FNY Investment Advisers, LLC Unchanged $030 shares

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Insider purchases and sales in Q3 2023

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
505Q4 21: 0 buyingQ4 21: 0 sellingQ1 22: 0 buyingQ1 22: 0 sellingQ1 22Q2 22: 0 buyingQ2 22: 0 sellingQ3 22: 0 buyingQ3 22: 0 sellingQ3 22Q4 22: 5 buyingQ4 22: 0 sellingQ1 23: 0 buyingQ1 23: 0 sellingQ1 23Q2 23: 0 buyingQ2 23: 0 sellingQ3 23: 1 buyingQ3 23: 0 sellingQ3 23
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20210—0——
Q1 20220—0——
Q2 20220—0——
Q3 20220—0——
Q4 20225$61.6m0——
Q1 20230—0——
Q2 20230—0——
Q3 20231$2.9m0——
DateInsiderTradeSharesPrice ValueTheir holding
2023-08-30 CHILDS JOHN W Director · By John W Childs 2013 Revocable Trust Bought 50,000 $18.44 $922.0k50.0k shares +3%
2023-08-04 CHILDS JOHN W Director · By John W Childs 2013 Revocable Trust Bought 100,000 $19.78 $2.0m100.0k shares +6%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q3 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Knoll Capital Management, LLC 13.24% of their portfolio MIAMI, FL 490,422490.4k $12.8m $12.8m 13.24% Added +40.0k +40,000